The multi-kinase inhibitor ec-70124 is a promising candidate for the treatment of flt3-itd-positive acute myeloid leukemia

HIGHLIGHTS

• who: Belen Lopez-Millan et al. from the Department of Biomedicine, Josep Carreras Research Institute, School of Medicine, GENYO, Centre for Genomics and Oncological Research, Pfizer, Universidad Granada, Junta Andalucu00eda, Investigaciu00f3n Sanitaria Princesa, Madrid, Spain have published the research work: The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia, in the Journal: (JOURNAL)
• what: The authors show that EC-70124 has a potent and selective cytotoxic effect on FLT3-ITDMUT_cells while sparing FLT3-ITDWT_cells and healthy hematopoietic (stem/progenitor) cells (HSPC).
• future . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.